SCHEMBL4620166

SCHEMBL4620166

CCC(=C(c1ccccc1)c1ccc(OCCO)cc1)c1ccccc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.89
CYP3A4 P08684 4/20 0.76
ESR1 P03372 11/20 0.74
NR1I2 O75469 2/20 0.73
ESR2 Q92731 8/20 0.72
MAPT P10636 3/20 0.72
PSMB1 P20618 3/20 0.72
CYP1A2 P05177 2/20 0.72
MEN1 O00255 2/20 0.72
TP53 P04637 2/20 0.72
KMT2A Q03164 2/20 0.72
PSMB5 P28074 2/20 0.72
NPC1 O15118 1/20 0.72
PRKD3 O94806 1/20 0.72
ABCB11 O95342 1/20 0.72
EGFR P00533 1/20 0.72
GBA1 P04062 1/20 0.72
NR3C1 P04150 1/20 0.72
ERBB2 P04626 1/20 0.72
PRKCG P05129 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11370966 1.00 CYP19A1 (0.89) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL4620164 1.00 CYP19A1 (0.89) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL31167386 0.94 CYP19A1 (1.00) CYP19A1CYP3A4ESR1ESR2MAPT
SCHEMBL11254955 0.92 CYP19A1 (0.77) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL16579225 0.89 CYP19A1 (0.78) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL84895 0.89 CYP19A1 (0.78) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL14136921 0.88 CYP19A1 (0.71) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL3817784 0.88 NR1I2 (0.73) CYP19A1CYP3A4ESR1NR1I2ESR2
SCHEMBL3813077 0.88 CYP19A1 (0.89) CYP19A1CYP3A4ESR1NR1I2ESR2
Desmethyl Tamoxifen SCHEMBL1110844 0.86 CYP19A1 (1.00) CYP19A1CYP3A4ESR1NR1I2ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1889639-A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents ConjuChem Biotechnologies Inc. (CA) 2008-02-20 EP disclosed
EP-1212120-A2 METHODS AND COMPOSITIONS CONTAINING SUCCINIMIDE OR MALEIMIDE DERIVATIVES OF ANTINEOPLASTIC AGENTS, FOR PRODUCING LONG LASTING ANTINEOPLASTIC AGENTS Conjuchem, Inc. (CA) 2002-06-12 EP disclosed
WO-2001017614-A2 METHODS AND COMPOSITIONS CONTAINING SUCCINIMIDE OR MALEIMIDE DERIVATIVES OF ANTINEOPLASTIC AGENTS CONJUCHEM, INC. (CA) 2001-03-15 WO disclosed